Analysis of a novel class A β-lactamase OKP-B-6 of Klebsiella quasipneumoniae: structural characterisation and interaction with commercially available drugs.
Reinaldo BelliniIsabella Alvim GuedesLuciane Prioli CiapinaAna Tereza Ribeiro de VasconcelosLaurent Emmanuel DardenneMarisa Fabiana NicolásPublished in: Memorias do Instituto Oswaldo Cruz (2022)
This conclusion advantageously impacts the clinical control of the bacterial pathogens encoding OKP-B in their genome by using any effective, broad-spectrum, and multitarget inhibitor against SHV-containing bacteria.